PK and Tolerability of MR Formulations of Z944

• Research type

  Research Study

• Full title

  Open-label Study to Evaluate the Pharmacokinetics and Tolerability of Three Modified-Release Tablet Formulations of Z944 Against the Immediate-Release Formulation and to Evaluate the Pharmacokinetics of the Modified-Release Formulation Under Fasted And Fed Conditions

• IRAS ID

  149079

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Zalicus Pharmaceuticals Ltd c/o Zalicus Inc

• Eudract number

  2014-000257-37

• ISRCTN Number

  to be registered

• REC name

  Wales REC 2

• REC reference

  14/WA/0042

• Date of REC Opinion

  20 Feb 2014

• REC opinion

  Favourable Opinion